Reefer Sanity
Condition by condition

What cannabis helps, and how strong the proof is.

From FDA-approved seizure medicine to promising early trials, here's the research for each condition, with every finding labeled by strength of evidence.

The federal government now says it: cannabis is medicine.

HHS found that more than 30,000 licensed healthcare practitioners in 43 U.S. jurisdictions can recommend medical marijuana to more than 6 million registered patients for at least 15 conditions. The FDA found credible scientific support for its use in pain, appetite loss tied to certain conditions, and chemotherapy nausea55 105.

Strong evidence

Conclusive or substantial evidence: several good randomized trials, or an official approval.

Moderate evidence

Good studies with some uncertainty. Promising and supported.

Emerging evidence Early / lab research

Smaller human studies or lab research pointing to new uses. These are the leads scientists are chasing now.

Labels follow the evidence categories of the 2017 National Academies report10.

Strongest evidence

Approved and proven

FDA-approved

Epilepsy: Dravet, Lennox-Gastaut & TSC

The FDA approved Epidiolex, a purified cannabis-derived CBD medicine21. In Lennox-Gastaut syndrome, drop seizures fell by a median of 43.9% on CBD versus 21.8% on placebo90, and a second trial found 41.9% versus 17.2%91. CBD also cut convulsive seizures in children with Dravet syndrome22. In tuberous sclerosis complex, seizures dropped 48.6% on CBD versus 26.5% on placebo92.

Strong evidence

Chronic & nerve pain

The National Academies found conclusive or substantial evidence that cannabis treats chronic pain in adults11. In a placebo-controlled trial, smoked cannabis cut HIV nerve pain by 34% versus 17% on placebo, and 52% of patients got at least 30% relief95. Even low-dose vaporized cannabis relieved treatment-resistant nerve pain about as well as standard nerve-pain drugs96.

Strong evidence

Chemotherapy nausea & vomiting

Oral cannabinoids are proven anti-nausea medicines for chemotherapy11, and dronabinol and nabilone are FDA-approved for it21. In a randomized trial of a THC:CBD capsule added to standard anti-nausea drugs, complete response rose from 14% to 25%, and 83% of patients preferred cannabis to placebo93.

Strong evidence

Multiple sclerosis spasticity

Oral cannabinoids improve patient-reported MS spasticity (conclusive/substantial evidence)11. In a randomized trial of nabiximols (Sativex), a THC/CBD mouth spray, spasticity scores improved significantly versus placebo, and so did spasm frequency and sleep disturbance94.

FDA-approved

Appetite & weight loss

Dronabinol (THC) is FDA-approved for appetite loss with weight loss in people with AIDS21. The National Academies also found evidence that cannabis increases appetite and reduces weight loss in HIV/AIDS11.

Moderate evidence

Sleep & insomnia

The National Academies found moderate evidence that cannabinoids improve short-term sleep in people with sleep apnea, fibromyalgia, chronic pain, and MS11. In a randomized crossover trial in people with chronic insomnia, two weeks of a nightly cannabinoid extract improved insomnia scores and added about an hour of self-reported sleep a night98.

Growing evidence

Promising and building fast

These findings come from smaller trials and real-world patient studies. They're encouraging, and larger trials are underway.

Patient studies

Cancer symptom relief

In a large prospective study of cancer patients in Israel, the most common reasons for cannabis were sleep problems, pain, weakness, nausea, and poor appetite. Of patients who answered at six months, 95.9% reported improvement. Researchers called cannabis a well-tolerated, effective palliative option104.

Emerging evidence

Migraine & headache

Among 121 adults treated at Colorado clinics, migraines dropped from 10.4 to 4.6 a month with medical marijuana99. Across nearly 20,000 logged sessions, inhaled cannabis cut self-reported headache and migraine severity by about half, though the effect faded somewhat over time100.

Emerging evidence

Fibromyalgia

All 26 patients in an Israeli study reported significant improvement on every measure after starting medical cannabis, and half stopped their other fibromyalgia medications102. Cannabinoids also improve sleep in fibromyalgia (moderate evidence)11.

Emerging evidence

PTSD

In a year-long study, people with PTSD who used dispensary cannabis were 2.57 times more likely to no longer meet PTSD criteria than non-users44. A review found cannabinoids may help with PTSD anxiety, memory processing, and sleep45.

Emerging evidence

Social anxiety

A single 600 mg dose of CBD before a public-speaking test reduced anxiety, mental impairment, and discomfort in people with social anxiety disorder, bringing them close to people without the disorder97. A trial of CBG, a lesser-known cannabinoid, also reduced anxiety and stress113. See Cannabinoids & Terpenes.

Emerging evidence

Crohn's disease

In one trial, 10 of 11 Crohn's patients on THC-rich cannabis responded, versus 4 of 10 on placebo43. In a later randomized trial, eight weeks of CBD-rich cannabis oil significantly improved symptoms and quality of life (from 74 to 91 on the scale, versus no change on placebo). Inflammation markers didn't change, so researchers want longer studies101.

Patient survey

Endometriosis

In a national Australian survey, women with endometriosis who used cannabis rated its pain relief 7.6 out of 10, and 56% cut their other medications by at least half. They also reported better sleep and less nausea103.

Emerging evidence

Tourette syndrome & brain injury

The National Academies found evidence that THC capsules improve Tourette symptoms, and that cannabinoids are linked to better survival and outcomes after traumatic brain injury or brain bleeding11.

Cutting back on alcohol or opioids?That research has its own page: The Exit Drug. For brain-protection research and THCA, see The Science.
Partner with your doctorCannabis can interact with other medicines. The World Health Organization notes that most side effects reported with CBD may come from interactions with medications patients already take108. Tell your doctor what you use.